Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9278996
APP PUB NO 20150225455A1
SERIAL NO

14430059

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a dolastatin-10 derivative having excellent anticancer activity, a method of producing the same and anticancer drug composition containing the same as an active ingredient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CELLTRION INCINCHON SOUTH KOREA INCHEON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cho, Eun Joo Gyeonggi-do, KR 5 4
Choi, Joon hun Gyeonggi-do, KR 6 22
Choi, Young Mi Gyeonggi-do, KR 5 12
Hong, Seung Suh Seoul, KR 10 28
Jeong, Jin-kyo Seoul, KR 2 3
Lee, Jong-hyoup Gyeonggi-do, KR 15 64
Lee, Min Seob Incheon, KR 23 468
Park, Sung Jun Gyeonggi-do, KR 551 10774
Park, Young Jun Gyeonggi-do, KR 67 382
Song, Hyunnam Gyeonggi-do, KR 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00